125 related articles for article (PubMed ID: 760681)
21. [Comparative effects of desiccated thyroid gland and sodium salt of L-thyroxine in the treatment of hypothyroidism].
Górowski T; Puciłowska J; Wernic K
Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):768-70. PubMed ID: 2701751
[TBL] [Abstract][Full Text] [Related]
22. Early change of thyroid hormone concentration after 131I treatment in patients with solitary toxic adenoma.
Pirnat E; Fidler V; Zaletel K; Gaberscek S; Hojker S
Nuklearmedizin; 2002; 41(4):178-83. PubMed ID: 12224401
[TBL] [Abstract][Full Text] [Related]
23. Elevations of thyroid-stimulating hormone during acute nonthyroidal illness.
Wong ET; Bradley SG; Schultz AL
Arch Intern Med; 1981 Jun; 141(7):873-5. PubMed ID: 7235805
[TBL] [Abstract][Full Text] [Related]
24. Assessment of thyroid function with hormone assays.
Liewendahl K
Ann Chir Gynaecol; 1983; 72(3):84-9. PubMed ID: 6414358
[TBL] [Abstract][Full Text] [Related]
25. Suppression of thyroid radioiodine uptake by various doses of stable iodide.
Sternthal E; Lipworth L; Stanley B; Abreau C; Fang SL; Braverman LE
N Engl J Med; 1980 Nov; 303(19):1083-8. PubMed ID: 7421914
[TBL] [Abstract][Full Text] [Related]
26. Thyroid function in patients treated with radioactive iodine for thyrotoxicosis.
Tunbridge WM; Harsoulis P; Goolden AW
Br Med J; 1974 Jul; 3(5923):89-92. PubMed ID: 4855207
[TBL] [Abstract][Full Text] [Related]
27. Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis.
Sawers JS; Toft AD; Irvine WJ; Brown NS; Seth J
J Clin Endocrinol Metab; 1980 Feb; 50(2):226-9. PubMed ID: 7354108
[TBL] [Abstract][Full Text] [Related]
28. Modifications of T3, T4, TSH in thyrotoxic crisis and in thyrotoxic coma after treatment with I131.
Melloni GF; Lureti GF; Minoja G; Melloni CF
Boll Soc Ital Biol Sper; 1977 Dec; 53(23):2269-75. PubMed ID: 416838
[No Abstract] [Full Text] [Related]
29. Individual plasma ghrelin changes in the same patients in hyperthyroid, hypothyroid and euthyroid state.
Ruchala M; Gurgul E; Stangierski A; Wrotkowska E; Moczko J
Peptides; 2014 Jan; 51():31-4. PubMed ID: 24184592
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the TSH and T3 response to exogenous TRH in patients made euthyroid after treatment with I 131 for hyperthyroidism].
Caputo M; Venerucci D; Trucchi M; Menozzi C; Biassoni P; Santaniello B; Bagnasco M; Ferrini O
Arch Maragliano Patol Clin; 1978; 34(1):15-26. PubMed ID: 122175
[No Abstract] [Full Text] [Related]
31. Measurement of free thyroxine and free triiodothyronine in asymptomatic subjects with high concentrations of serum TSH and a history of radioiodine therapy.
Franklyn JA; Sheppard MC; Ramsden DB; Hoffenberg R
Clin Endocrinol (Oxf); 1984 May; 20(5):527-30. PubMed ID: 6430600
[TBL] [Abstract][Full Text] [Related]
32. [Diminution of thyroid stimulating hormone level but normal levels of thyroid hormones. Demonstration of occult hyperthyroidism].
Schlienger JL; Klerlein M; Sapin R; Demangeat JL; Imler M
Presse Med; 1989 Apr; 18(14):707-10. PubMed ID: 2471184
[TBL] [Abstract][Full Text] [Related]
33. Treatment of hyperthyroidism with potassium iodide.
Philippou G; Piperingos G; Souvatzoglou A; Koutras DA; Moulopoulos SD
Exp Clin Endocrinol; 1991 May; 97(2-3):308-11. PubMed ID: 1915648
[TBL] [Abstract][Full Text] [Related]
34. Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosis.
Toft AD; Irvine WJ; Hunter WM; Ratcliffe JG; Seth J
J Clin Endocrinol Metab; 1974 Sep; 39(3):607-9. PubMed ID: 4412033
[No Abstract] [Full Text] [Related]
35. [Proceedings: Fluctuation of blood T3 and T4 levels in hyperthyroidism during therapy].
Mitsuma T; Hirooka Y; Yamauchi K; Nagasaka A; Nihei R
Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):404. PubMed ID: 4476483
[No Abstract] [Full Text] [Related]
36. 5-fluorouracil-induced increase of total serum thyroxine and triiodothyronine.
Beex L; Ross A; Smals A; Kloppenborg P
Cancer Treat Rep; 1977 Oct; 61(7):1291-5. PubMed ID: 589596
[TBL] [Abstract][Full Text] [Related]
37. Incidence of hypothyroidism after 131I therapy for hyperthyroidism. Relation to pretherapy serum levels of T3, T4 and thyroid antibodies.
Lundell G; Holm LE; Ljunggren JG; Wasserman J
Acta Radiol Oncol; 1981; 20(4):225-30. PubMed ID: 6277151
[TBL] [Abstract][Full Text] [Related]
38. The assessment of 125I treatment of thyrotoxicosis.
Bremner WF; Spencer CA; Ratcliffe WA; Greig WR; Ratcliffe JG
Clin Endocrinol (Oxf); 1976 May; 5(3):225-34. PubMed ID: 954217
[TBL] [Abstract][Full Text] [Related]
39. Serum triiodothyronine 7-15 years after fractionated low dose radioiodine therapy of thyrotoxicosis.
Herrmann J; Schaps D; Rusche HJ; Berger M; Krüskemper HL; von zur Hühlen A; Hackenberg K; Reinwein D
Clin Endocrinol (Oxf); 1975 Mar; 4(2):205-12. PubMed ID: 48437
[TBL] [Abstract][Full Text] [Related]
40. Selective pituitary resistance to thyroid hormone after treatment of a toxic multinodular goiter.
Vesely DL
South Med J; 1988 Sep; 81(9):1173-6. PubMed ID: 3420449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
